Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells

Cancer is a huge challenge for people worldwide. High reactive oxygen species (ROS) levels are a recognized hallmark of cancer and an important aspect of cancer treatment research. Abnormally elevated ROS levels are often attributable to alterations in cellular metabolic activities and increased oxi...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Metabolites Ročník 13; číslo 7; s. 796
Hlavní autori: Zhao, Yongxia, Ye, Xiaochun, Xiong, Zhifeng, Ihsan, Awais, Ares, Irma, Martínez, Marta, Lopez-Torres, Bernardo, Martínez-Larrañaga, María-Rosa, Anadón, Arturo, Wang, Xu, Martínez, María-Aránzazu
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland MDPI AG 27.06.2023
MDPI
Predmet:
ISSN:2218-1989, 2218-1989
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Cancer is a huge challenge for people worldwide. High reactive oxygen species (ROS) levels are a recognized hallmark of cancer and an important aspect of cancer treatment research. Abnormally elevated ROS levels are often attributable to alterations in cellular metabolic activities and increased oxidative stress, which affects both the development and maintenance of cancer. Moderately high levels of ROS are beneficial to maintain tumor cell genesis and development, while toxic levels of ROS have been shown to be an important force in destroying cancer cells. ROS has become an important anticancer target based on the proapoptotic effect of toxic levels of ROS. Therefore, this review summarizes the role of increased ROS in DNA damage and the apoptosis of cancer cells caused by changes in cancer cell metabolism, as well as various anticancer therapies targeting ROS generation, in order to provide references for cancer therapies based on ROS generation.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2218-1989
2218-1989
DOI:10.3390/metabo13070796